Updates are available Correction dated 2020-07-21
Click to view Correction: https://doi.org/10.1038/s41416-020-0998-0
-
Authors
Kagohara, Luciane T.
Zamuner, Fernando
Davis-Marcisak, Emily F.
Sharma, Gaurav
Considine, Michael
Allen, Jawara
Yegnasubramanian, Srinivasan
Gaykalova, Daria A.
Fertig, Elana J.
- License Information
-
More Information
Article History
Received: 5 November 2019
Revised: 19 March 2020
Accepted: 1 April 2020
First Online: 4 May 2020
Change Date: 21 July 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-020-0998-0
Ethics approval and consent to participate
: The human HNSCC cell line SCC25 was purchased from American Type Culture Collection (ATCC) and the cell lines UM-SCC-1 (SCC1) and UM-SCC-6 (SCC6) were obtained from University of Michigan. Both were established at the University of Michigan with written informed consent obtained from the patient and with the approval of the study by the Medical School Institutional Review Board.
: Not applicable.
: Unless otherwise specified, all genomics analyses were performed in R. All transcriptional (single cell and bulk) and epigenetic data of the cell lines from this paper have been deposited in GEO (ExternalRef removed, ExternalRef removed and ExternalRef removed).
: E.J.F. serves as a consultant for Champions Oncology. The remaining authors declare no competing interests.
: This work was supported by NIH Grants R01CA177669, R21DE025398, P30CA006973, R01DE017982, SPORE P50DE019032, and the Johns Hopkins University Catalyst Award.
